This compound is a modified nucleoside derivative used as a pharmaceutical intermediate in the synthesis of nucleoside analogs. It features a benzoyl-protected amino group and a methyl substituent on the cytosine ring, along with a deoxyribose sugar moiety.
Geltungsbereich: Die Informationen auf dieser Seite betreffen die Identifizierung von Chemikalien sowie industrielle Liefer-, Forschungs- und Produktionskontexte. Sie stellen keine Heilversprechen, medizinische Beratung oder Anwendungshinweise für Arzneimittel dar.
Beschaffen oder liefern Sie diese Verbindung?
Inventar einstellen oder Kaufanfrage stellen
CAS 104579-02-4
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
1,2,3,5-Tetraacetyl-beta-D-ribofuranose
Pharmaceutical intermediate for nucleoside synthesis
1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose
Pharmaceutical intermediate for nucleoside synthesis
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-5-methylcytidine
Nucleoside intermediate for oligonucleotide synthesis
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester
Pharmaceutical intermediate for ambrisentan impurities
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
Pharmaceutical intermediate for synthetic routes
N-(2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetamide
Pharmaceutical intermediate for drug synthesis
N-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
VYJDMDIVDHHLGK-BFHYXJOUSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3C[C@@H]([C@H](O3)CO)O
—